Epidemiology of hormone-associated cancers as a reflection of age

Advances in Experimental Medicine and Biology

Volumn 630, Issue , 2008, Pages 57-71

  Ukraintseva, Svetlana V ^a   Arbeev, Konstantin G ^a   Yashin, Anatoli I ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE;

AGE; AGING; CONCEPT FORMATION; FORECASTING; HUMAN; INCIDENCE; MORTALITY; NEOPLASM; PHYSIOLOGY; REVIEW;

AGE FACTORS; AGING; CONCEPT FORMATION; FORECASTING; HORMONES; HUMANS; INCIDENCE; NEOPLASMS; NEOPLASMS, HORMONE-DEPENDENT;

EID: 49649096683     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78818-0_5     Document Type: Article

References (47)

1. Ries LAG, Melbert D, Krapcho M et al. eds. SEER cancer statistics review, 1975-2004. Bethesda, MD: National Cancer Institute, 2007 (http://seer.cancer. gov/csr/1975-2004/, based on November 2006 SEER data submission, posted to the SEER web site, 2007).
2. Stewart BW, Kleihues P. eds. World cancer report. IARC, 2003
3. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37(Suppl 8):S4-66.
4. Sener SF, Grey N. The global burden of cancer. J Surg Oncol 2005; 92(1):1-3. (Pubitemid 41416420)
5. IARC. Cancer incidence in five continents. Volumes I-VIII. IARC Sci Publ Lyon: IARC Press, 1965-2002.
6. IARC. Cancer incidence in five continents. Parkin DM, Whelan SL, Ferlay J et al. eds. Volume VII. IARC Sci Publ No 143. Lyon: IARC Press, 1997.
7. IARC. Cancer incidence in five continents. Parkin DM, Whelan SL, Ferlay J et al. eds. Cancer incidence in five continents, Vol VIII. IARC Sci Publ No. 155. Lyon: IARC Press, 2002.
8. IARC monographs on the evaluation of carcinogenic risks to humans. Vol 1-88. Lyon: IARC Press, 1972-2006. http://monographs.iarc.fr/ENG/Monographs/ allmonos90.php.
9. IARC monographs on the evaluation of carcinogenic risks to humans. Vol 72. Lyon: IARC Press, 1999 (data on hormonal contraception and postmenopausal hormonal therapy).
10. Ries LAG, Eisner MP, Kosary CL et al. eds. SEER cancer statistics review, 1973-1998. Bethesda, MD: National Cancer Institute, 2001, posted to the SEER web site in 2001.
11. Rainsford J, Cohen P, Dix D. On the role of aging in cancer incidence: Analysis of the lung cancer data. Anticancer Res 1985; 5(4):427-30.
12. Volpe EW, Dix D. On the role of aging in cancer incidence: Cohort analyses of the lung cancer data. Anticancer Res 1986; 6(6):1417-20.
13. Ukraintseva SV, Yashin AI. Economic progress as cancer risk factor: Part II. Why is overall cancer risk higher in more developed countries? Max Planck Institute WP-2005-022, 2005. http://www.demogr. mpg.de/papers/working/wp-2005- 022.pdf
14. Kuramoto K, Matsushita S, Esaki Y et al. [Prevalence, rate of correct clinical diagnosis and mortality of cancer in 4,894 elderly autopsy cases]Nippon Ronen Igakkai Zasshi 1993; 30(1):35-40. (in Japanese). (Pubitemid 23142468)
15. Stanta G, Campagner L, Cavallieri F et al. Cancer of the oldest old. What we have learned from autopsy studies. Clin Geriatr Med 1997; 13(1):55-68. (Pubitemid 27084043)
16. Pompei F, Polkanov M, Wilson R. Age distribution of cancer in mice: The incidence turnover at old age. Toxicol Ind Health 2001; 17(1):7-16. (Pubitemid 33721022)
17. Anisimov VN, Ukraintseva SV, Yashin AI. Cancer in experimental animals: Does it tell us about cancer in humans? Nature Reviews Cancer 2005; 5(10):807-19. (Pubitemid 41408566)
18. Arbeev KG, Semenchenko AV, Anisimov VN et al. Relationship between cancer and aging: Experimental evidence and mathematical modeling considerations. Presented at: Population Association of America 2004 Annual Meeting. USA: Boston, MA, 2004.
19. Vaupel J, Yashin AI. Cancer Rates over Age, Time and Place: Insights from Stochastic Models of Heterogeneous Populations. WP #88-01-1 of the Center for Population Analysis and Policy, University of Minnesota, 1988.
20. Ukraintseva SV, Yashin AI. How individual aging may influence human morbidity and mortality patterns. Mech Ageing Dev 2001; 122:1447-60. (Pubitemid 32721926)
21. Ukraintseva SV, Yashin AI. Individual aging and cancer risk: How are they related? Demographic Research 2003; 9-8.
22. Kehinde EO, Akanji AO, Memon A et al. Prostate cancer risk: The significance of differences in age related changes in serum conjugated and unconjugated steroid hormone concentrations between Arab and Caucasian men. Int Urol Nephrol 2006; 38(1):33-44.
23. Severi G, Morris HA, MacInnis RJ et al. Circulating steroid hormones and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006; 15(1):86-91.
24. Giovannucci E, Liu Y, Platz EA et al. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 2007; 121:1571-8. (Pubitemid 47328718)
25. Brouwer IA, Katan MB, Zock PL. Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: A meta-analysis. Journal of Nutrition 2004; 134(4):919-22. (Pubitemid 38456264)
26. Zhang Y, Kreger BE, Dorgan JF et al. Parental age at child's birth and son's risk of prostate cancer. The Framingham Study. Am J Epidemiol 1999; 150(11):1208-12.
27. Ewertz M, Duffy SW, Adami HO et al. Age at first birth, parity and risk of breast cancer: A meta-analysis of 8 studies from the Nordic countries. Int J Cancer 1990; 46(4):597-603. (Pubitemid 20355746)
28. Dupont WD, Page DL. Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer. Am J Epidemiol 1987; 125(5):769-79. (Pubitemid 17066476)
29. Zhang Y, Cupples LA, Rosenberg L et al. Parental ages at birth in relation to a daughter's risk of breast cancer among female participants in the Framingham Study (United States). Cancer Causes Control 1995; 6(1):23-9.
30. Choi JY, Lee KM, Park SK et al. Association of paternal age at birth and the risk of breast cancer in offspring: A case control study. BMC Cancer 2005; 5:143.
31. Ravdin PM, Cronin KA, Howlader N et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 2007; 356(16):1670-4. (Pubitemid 46631679)
32. Katalinic A, Rawal R. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat 2007 [Epub ahead of print].
33. Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-333. (Pubitemid 34761611)
34. Steinberg KK, Thacker SB, Smith SJ et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991; 265(15):1985-90.
35. Health for all. Data Base. WHO Regional Office for Europe, 2000
36. EUCAN: Cancer incidence, mortality and prevalence in the European Union in 1996, version 3.1.
37. Ferlay J, Bray F, Sankila R et al. IARC Cancer Base No. 4. Lyon: IARC Press, 1999 (a product of European Network of Cancer Registries).
38. Health in Russia. 1999 Statistics. Russian Ministry of Health publication, 2000.
39. Lacey Jr JV, Mink PJ, Lubin JH et al. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 2002; 288(3):334-41. (Pubitemid 34761612)
40. Li C, Heidt DG, Dalerba P et al. Identification of pancreatic cancer stem cells. Cancer Res 2007; 67(3):1030-7.
41. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57:43-66.
42. GLOBOCAN: Cancer incidence and mortality worldwide. Ferlay J, Parkin DM, Pisani P. eds. IARC Cancer Base No 3. Lyon: IARC Press, 1998.
43. Health, United States, 1996-97 and Injury Chartbook. National Center for Health Statistics. Hyattsville, Maryland: 1997. http://www/cdc.gov/nchs/hus.htm
44. Smith D. Changing causes of death of elderly people in the United States, 1950-1990. Gerontology 1998; 44:331-5.
45. Smith D. Resistance to causes of death: A study of cancer mortality resistance in the oldest old. In: Robine JM, ed. The paradoxes of longevity. Springer Verlag, 1999:61-71.
46. Aksel E, Dvoirin V. [Statistics of Malignant Neoplasms.]. Moscow: VONTS AMN SSSR, 1991 (in Russian).
47. Jemal A, Tiwari RC, Murray T et al. Cancer statistics, 2004. CA Cancer J Clin 2004; 54:8-29.